Home
News
Interviews
Companies
Videos
Subscribe
Spotlights
Christopher J. Moreau | Chief Executive Officer, Algernon Pharmaceuticals
Read the Interview
Miriam Volat | Director of the Indigenous Medicine Conservation Fund
Read the Interview
Julia Joyes | Research Director at TheraPsil
Read the Interview
Carey Turnbull | Co-founder and CEO of B.More
Read the Interview
Dr. Alan K. Davis | Director, Center for Psychedelic Drug Research and Education
Read the Interview
Amanda Feilding | Founder and Executive Director, Beckley Foundation
Read the Interview
Amir Inamdar, MBBS | Chief Medical Officer, Cybin
Read the Interview
Psychedelics & Emerging Therapies Practice | Husch Blackwell Law Firm
Read the Interview
Aaron Bartlone | Chief Operating Officer, Cybin
Read the Interview
Daniel Carcillo | Founder and CEO, Wesana Health
Read the Interview
Dr. Albert Garcia-Romeu | Johns Hopkins University School of Medicine
Read the Interview
Spencer Hawkswell | CEO, TheraPsil
Read the Interview
Chris Koddermann | Co-founder and Chair of Board, ITPRI
Read the Interview
Mary-Elizabeth Gifford | Executive Vice-President, Psyence Group
Read the Interview
Matthew Singh | CCO, Psyched Wellness
Read the Interview
Dr. Neil Maresky | CEO, Psyence Group
Read the Interview
Ryan Moss | Director of Research, Filament Health
Read the Interview
Daniel Cohen | CEO, Pharmadrug
Read the Interview
William (Bill) J. Ciprick | CEO, Optimi Health
Read the Interview
Mark Haden | Scientific Advisory Board, Clearmind
Read the Interview
Doug Drysdale | CEO, Cybin Corp
Read the Interview
Dr. Elizabeth Nielson | Co-Founder and Lead Trainer, Fluence
Read the Interview
Dr. Corey Hilmas | Chief Regulatory Officer, KGK Science
Read the Interview
Christopher J. Moreau | Chief Executive Officer, Algernon Pharmaceuticals
Read the Interview
Dr. Paul Van Slyke | Chief Scientific Officer, PharmaDrug
Read the Interview
Dr. Ty Tashiro, PhD | Senior Translational & Psychometric Architect, MINDCURE
Read the Interview
Christian Angermayer | Founder, atai Life Sciences
Read the Interview
Philip Young | CEO, Lobe Sciences
Read the Interview
Nick von Christierson | CEO & Co-Founder, Woven Science
Read the Interview
Joel Raskin, CMO | MINDCURE
Read the Interview
George Mashour, M.D., Ph.D | Tryp Therapeutics
Read the Interview
Dr. Jennifer Miller | Principal Investigator, Tryp Therapeutics
Read the Interview
Damon Michaels | Director, COO, & Co-Founder, Mydecine Innovations
Read the Interview
Justin Kirkland | CSO Optimi Health
Read the Interview
Dr. Carl Laird Birmingham | Advisory board & Consultant, NeonMind Biosciences
Read the Interview
Ben Lightburn | CEO, Filament Health
Read the Interview
Joseph Tucker | CEO, MagicMed Industries
Read the Interview
Jerry March | COO, New York Ketamine Infusions
Read the Interview
Douglas K. Gordon | CEO, Silo Wellness
Read the Interview
Dr. Rick Strassman | DMT Stroke Program Consultant, Algernon Pharmaceuticals
Read the Interview
Najla Guthrie | CEO & President, KGK Science
Read the Interview
Dr. Mike Dow | Field Trip Health
Read the Interview
Kelsey Ramsden | CEO, MINDCURE
Read the Interview
Evan Levine | Chairman & CEO, PsyBio Therapeutics
Read the Interview
Judy Blumstock | CEO & Founder, Diamond Therapeutics
Read the Interview
Professor David Nutt | DMT Stroke Consultant , Algernon Pharmaceuticals
Read the Interview
Jeff Stevens | CEO, Psyched Wellness
Read the Interview
Dane Stevens | CMO & Director, Optimi Health
Read the Interview
Dr. Glen Z. Brooks | Medical Director & Founder, New York Ketamine Infusions
Read the Interview
Greg McKee | CEO, Tryp Therapeutics
Read the Interview
Dr. Evan Wood | Chief Medical Officer, Numinus Inc.
Read the Interview
Natalie Dolphin | Director, Marketing, MagicMed Industries
Read the Interview
Dr. Robin Carhart-Harris | Scientific Advisory Board, Tryp Therapeutics
Read the Interview
William Garner, M.D. | Executive Director, Tryp Therapeutics
Read the Interview
Dr. Ivan Casselman | Chief Psychedelic Officer, Havn Life Sciences
Read the Interview
JJ Wilson | Chairman of the Board, Optimi Health
Read the Interview
Prof. Dr. Eric Vermetten | Scientific Advisory Board Member, Mydecine Innovations
Read the Interview
Rob Tessarolo | President & CEO, NeonMind Biosciences
Read the Interview
Dr. Jill Hagel, Chief Technology Officer | Enveric Biosciences
Read the Interview
Jeff Siegel | Managing Partner, JLS Fund
Read the Interview
David Harder | Founder & Co-CEO, Atma Journey Centers
Read the Interview
Nick Milne | Co-Founder and CSO at Octarine Bio
Read the Interview
Maghsoud Dariani | Chief Science Officer, Lobe Sciences
Read the Interview
Jody Aufrichtig | Co-Founder and President The Psyence Group
Read the Interview
Brett Greene | Chief Innovations Officer, Cybin Inc.
Read the Interview
Nethaji Gallage | CEO & Co-Founder, Octarine Bio
Read the Interview
Ben Greenfield | Biohacker and New York Times Best Selling Author
Read the Interview
Dr. Marvin Hausman | Chief of Scientific Advisory Board, Nova Mentis
Read the Interview
Spencer Hawkswell | CEO of TheraPsil
Read the Interview
Dr. Denton Hoyer | Scientific Advisor, Mydecine
Read the Interview
Paul Austin | Founder, Third Wave
Read the Interview
Dr. James Gilligan | President and Chief Scientific Officer, Tryp Therapeutics
Read the Interview
Dr Rakesh Jetly | Chief Medical Officer, Mydecine
Read the Interview
Professor David Nutt | Board of Directors, Psyched Wellness
Read the Interview
Larry Norder | VP Manufacturing, Tryp Therapeutics
Read the Interview
Tom D'orazio | COO, Tryp Therapeutics
Read the Interview
Joseph del Moral | Founder & CEO, Field Trip Health
Read the Interview
Robert Roscow | CSO, Mydecine Innovations Group
Read the Interview
Derrick Welsh | Founder, Psilocin Pharma
Read the Interview
Dr. David Mokler | Havn Life Sciences
Read the Interview
Dr. Peter Facchini | MagicMed Industries
Read the Interview
Gary Leong | Chief Scientific Officer, HAVN Life Sciences
Read the Interview
Doug Drysdale | CEO, Cybin Corp
Read the Interview
Miri Halperin Wernli | President, MindMed
Read the Interview
Vic Neufeld | Executive Chairman, Havn Life Sciences
Read the Interview
Dr. Reid Robison | Chief Medical Officer, Novamind Ventures
Read the Interview
Dr. Joseph Tucker | Founder & CEO, MagicMed Industries
Read the Interview
Irie Selkirk | Co-Founder, Rise Wellness Retreat
Read the Interview
Garyn Angel | Founder & CEO, Magical Brands
Read the Interview
Lorne Gertner | Chairman, CannaGlobal Wellness
Read the Interview
James Kuo, MD, MBA | Director, Tryp Therapeutics
Read the Interview
Steve Sadoff | CEO, CannaGlobal
Read the Interview
Dr. David E. Nichols | Founding President, Hefter Research Institute
Read the Interview
Dr. Michael Verbora | Field Trip Health
Read the Interview
Ben Nikolaevsky | CEO, Pure Extracts
Read the Interview
Adam Halberstadt | UC San Diego
Read the Interview
Next
